Hansjoerg Fritsch

Title: The Innovative Contributions of Hansjoerg Fritsch

Introduction

Hansjoerg Fritsch, an inventive mind hailing from Limburgerhof, Germany, has made notable strides in the field of bioregulators. With a unique patent to his name, he has contributed to advancements in the understanding and application of substituted oxime-ethers.

Latest Patents

Fritsch holds a patent for "Substituted oxime-ethers and their use as bioregulators to lower the," which details substituted oxime-ethers of specific formulae. In this patent, R1 and R2 are independently defined as C1-C6 alkyl groups, with n being either 2 or 3, and R3 representing hydrogen or a C1-C6 alkyl group.

Career Highlights

Hansjoerg Fritsch is associated with BASF Aktiengesellschaft, a globally recognized leader in chemical production and innovation. His work in the company has allowed him to leverage vast resources and expertise, enhancing his contributions to the scientific community.

Collaborations

Throughout his career, Fritsch has collaborated with esteemed coworkers such as Guenter Schulz and Wolfgang Will. These partnerships have undoubtedly enriched his work and contributed to the successful outcomes of various projects.

Conclusion

Hansjoerg Fritsch exemplifies the spirit of innovation within the chemical industry. His patent on substituted oxime-ethers signifies a meaningful contribution to the field of bioregulators, showcasing the crucial role of inventors in science and technology. As he continues to work at BASF Aktiengesellschaft, the future holds promise for further developments and inventions that may arise from his expertise and creative endeavors.